167 related articles for article (PubMed ID: 8813558)
1. Opposite effects of alcuronium on agonist and on antagonist binding to muscarinic receptors.
Maass A; Mohr K
Eur J Pharmacol; 1996 Jun; 305(1-3):231-4. PubMed ID: 8813558
[TBL] [Abstract][Full Text] [Related]
2. Potentiation by alcuronium of the antimuscarinic effect of N-methylscopolamine in guinea pig left atria.
Maass A; Kostenis E; Mohr K
Eur J Pharmacol; 1995 Jan; 272(1):103-6. PubMed ID: 7713140
[TBL] [Abstract][Full Text] [Related]
3. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
[TBL] [Abstract][Full Text] [Related]
4. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
Sharif NA; Williams GW; DeSantis LM
Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362
[TBL] [Abstract][Full Text] [Related]
5. Positive allosteric action of alcuronium on solubilized cardiac muscarinic receptors.
Musílková J; Tucek S
Neurochem Int; 1995; 27(4-5):337-43. PubMed ID: 8845734
[TBL] [Abstract][Full Text] [Related]
6. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
7. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
Schröter A; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
[TBL] [Abstract][Full Text] [Related]
8. Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors.
Proska J; Tucek S
Eur J Pharmacol; 1996 Jun; 305(1-3):201-5. PubMed ID: 8813554
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist.
Zahn K; Eckstein N; Tränkle C; Sadée W; Mohr K
J Pharmacol Exp Ther; 2002 May; 301(2):720-8. PubMed ID: 11961078
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
11. Competition between positive and negative allosteric effectors on muscarinic receptors.
Proska J; Tucek S
Mol Pharmacol; 1995 Oct; 48(4):696-702. PubMed ID: 7476896
[TBL] [Abstract][Full Text] [Related]
12. Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors.
Franken C; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):107-12. PubMed ID: 10685864
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of quinidine on rat heart muscarinic receptors.
Waelbroeck M; De Neef P; Robberecht P; Christophe J
Life Sci; 1984 Sep; 35(10):1069-76. PubMed ID: 6482646
[TBL] [Abstract][Full Text] [Related]
14. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
Krejcí A; Tucek S
Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.
Proska J; Tucek S
Mol Pharmacol; 1994 Apr; 45(4):709-17. PubMed ID: 8183250
[TBL] [Abstract][Full Text] [Related]
16. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
[TBL] [Abstract][Full Text] [Related]
17. Prevention of guanine nucleotide-induced reductions in muscarinic agonist binding to rabbit ileal submucosal membranes by lidamidine and tetracaine.
Bleakman D; Naftalin RJ
Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):366-72. PubMed ID: 2900471
[TBL] [Abstract][Full Text] [Related]
18. Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.
Tränkle C; Mohr K
Mol Pharmacol; 1997 Apr; 51(4):674-82. PubMed ID: 9106634
[TBL] [Abstract][Full Text] [Related]
19. [3H]N-methylscopolamine dissociation from muscarine receptors affected by low concentrations of allosteric modulators.
Christopoulos A; Mitchelson F
Eur J Pharmacol; 1995 Aug; 290(3):259-62. PubMed ID: 7589221
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic binding sites on bovine pulmonary arterial endothelial cells in culture.
Aronstam RS; Ryan US; Catravas JD
Pharmacology; 1992; 44(6):324-33. PubMed ID: 1508962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
